DeepMirror Launches Early Access Programme for Its Intuitive Molecular Drug Design Software

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery CAMBRIDGE, England — DeepMirror, a University of Cambridge spin-out company developing intui

By: financialpost.com

Dec 11 2023
0
0 Views

CAMBRIDGE, England -- DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the launch of its Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. The software allows users to tap into AI-driven insights to improve and accelerate molecular design across the drug discovery pipeline through a secure and user-friendly interface which makes AI-powered drug discovery as simple as using a spreadsheet. Read More